vTv Therapeutics (VTVT) IPO Opens 7% Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
vTv Therapeutics Inc. Announces Pricing of Initial Public Offering
July 29, 2015 9:48 PM EDTHIGH POINT, N.C.--(BUSINESS WIRE)-- vTv Therapeutics Inc. (the Company) (Nasdaq: VTVT) announced today the pricing of its initial public offering of 7,812,500 shares of its Class A common stock at a price to the public of $15.00 per share. All of the shares are being offered by the Company. In addition, the Company has granted the underwriters an option to purchase up to an additional 1,171,875 shares of Class A common stock. The shares of Class A common stock are expected to begin trading on the Nasdaq Global Market on July 30, 2015, under the symbol VTVT.
... More